Topiramate - NDC Database (Page 22)
68382-358 Nov 13, 2023
Topiramate 200 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
Topiramate 200 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
68382-498 Oct 24, 2024
Topiramate 50 mg Oral Capsule, Coated Pellets by Zydus Pharmaceuticals USA Inc.
Topiramate 50 mg Oral Capsule, Coated Pellets by Zydus Pharmaceuticals USA Inc.
68382-769 Sep 10, 2024
Topiramate 100 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Topiramate 100 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
68382-863 Sep 10, 2024
Topiramate 25 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Topiramate 25 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
68382-864 Sep 10, 2024
Topiramate 50 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
Topiramate 50 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
68462-218 Jul 16, 2024
Topiramate 15 mg Oral Capsule, Coated Pellets by Glenmark Pharmaceuticals Inc., USA
Topiramate 15 mg Oral Capsule, Coated Pellets by Glenmark Pharmaceuticals Inc., USA
68462-219 Jul 16, 2024
Topiramate 25 mg Oral Capsule, Coated Pellets by Glenmark Pharmaceuticals Inc., USA
Topiramate 25 mg Oral Capsule, Coated Pellets by Glenmark Pharmaceuticals Inc., USA
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.